SCHEMBL14499448

SCHEMBL14499448

COc1ccc(-c2cc(C)cc(C)c2)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.50
PDGFRA P16234 1/20 0.50
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HTT P42858 2/20 0.46
ACHE P22303 2/20 0.45
FFAR1 O14842 1/20 0.44
PTGS2 P35354 2/20 0.43
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTGS1 P23219 1/20 0.42
FPR2 P25090 1/20 0.41
CNR2 P34972 1/20 0.41
RORC P51449 1/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12326161 0.89 PDGFRB (0.58) PDGFRBPDGFRAMAPTKDM4EACHE
SCHEMBL8338270 0.85 ACHE (0.52) PDGFRBPDGFRAMAPTKDM4EACHE
SCHEMBL8401018 0.83 PDGFRB (0.53) PDGFRBPDGFRAMAPTKDM4EACHE
SCHEMBL15342384 0.83 PDGFRB (0.57) PDGFRBPDGFRAMAPTKDM4EHTT
SCHEMBL8824072 0.80 NPC1 (0.55) PDGFRBPDGFRAMAPTKDM4EFFAR1
Formaldehyde SCHEMBL28799624 0.80 TSHR (0.48) PDGFRBPDGFRAMAPTKDM4EACHE
SCHEMBL29644376 0.79 KDM4E (0.54) PDGFRBPDGFRAMAPTKDM4EHTT
SCHEMBL8264357 0.79 KDM4E (0.54) PDGFRBPDGFRAMAPTKDM4EHTT
SCHEMBL15342387 0.79 DYRK1A (0.52) PDGFRBPDGFRAMAPTKDM4EACHE
SCHEMBL1912033 0.79 DYRK1A (0.52) PDGFRBPDGFRAMAPTKDM4EACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070149570-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149570-A1 Piperidine derivative and use thereof TACR1, OPRL1, TRPV1 PDGFRB 239/4885PDGFRA 240/4885MAPT 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.